Searched for
SANDOZ SHAPE
Highs & Lows: Could the microdosing of psychedelics be a key missing piece in the mental health jigsaw?A Netflix documentary highlights the re-evaluation of mind-expanding substances like LSD, once banned but now experiencing a scientific ren...- There’s an explosion of data & digital opportunities in Indian healthcare: Vasant Narasimhan, CEO, NovartisOur chief focus for future investments will be: One on increasing our R&D footprint here over time. Second is data and digital.
- 25 years of reforms: Meet Indian banking sector's poster boys of liberalisationBesides playing an active role in rupee devaluation as deputy governor, Rangarajan laid the foundation for modern Indian banking.
- The colour purple that has left drug makers like Dr Reddy's Laboratories paleThe reference here has nothing to do with the Pulitzer-winning book of Alice Walker, but the actual colour that has pushed big pharma to pu...
- Sun Pharmaceutical acquires ailing Ranbaxy Laboratories for $4 billionFollowing the acquisition, the Ranbaxy brand will cease to exist and both the companies will be operated under one management.
- Lodestone to be bought by Infosys: Five ways in which the deal will helpWhile it’s still too early to say how Infosys buying Lodestone will play out, there are some immediately visible benefits. We list five of ...
- Ex-Teva Frank Pieters to lead Cipla's European respiratory businessCipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...
- No Indian co is a tier-I pharma player: GV Prasad, Dr Reddy'sIn a candid conversation, Dr Reddy’s Laboratories’ vice-chairman and MD, GV Prasad, talks about the strengths and weaknesses of the domesti...
- 'There's room for low-priced generics’Novartis has recognised the growth potential of rural India early on. ET caught up with Olivier Jarry, senior vice president (strategy and ...
Load More
